In recent years, much attention has been paid to studying the role of incretin hormones in regulating metabolism, especially in the context of diabetes and obesity treatment, with more emphasis on GLP-1. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.